Metacognitive Therapy for Comorbid Insomnia

This study has been withdrawn prior to enrollment.
(problems recruiting patients)
Sponsor:
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00235365
First received: October 7, 2005
Last updated: November 21, 2012
Last verified: November 2012

October 7, 2005
November 21, 2012
August 2009
January 2011   (final data collection date for primary outcome measure)
Scores on rating scales for sleep quality [ Time Frame: one year ] [ Designated as safety issue: No ]
Scores on rating scales for sleep quality
Complete list of historical versions of study NCT00235365 on ClinicalTrials.gov Archive Site
Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing. [ Time Frame: one year ] [ Designated as safety issue: No ]
Scores on rating scales for depression, psychiatric symptom severity, and cognitive processing.
Not Provided
Not Provided
 
Metacognitive Therapy for Comorbid Insomnia
Metacognitive Therapy for Patients With a Psychiatric Disorder and Comorbid Insomnia.

The purpose of this study is to determine the effect of meta-cognitive therapy for insomnia.

This study is a randomized controlled trial with 50 patients with a psychiatric disorder and insomnia. The patients will be randomized into two groups of 25 patients. The first group receives meta-cognitive therapy, whereas the second group will be assigned to a waiting list control.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Secondary Insomnia
  • Behavioral: meta-cognitive therapy
    Meta-cognitive therapy
  • Other: waiting list
    waiting list control
  • Experimental: meta-cognitive therapy
    meta-cognitive therapy
    Intervention: Behavioral: meta-cognitive therapy
  • Active Comparator: waiting list
    waiting list control
    Intervention: Other: waiting list
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
January 2011
January 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Insomnia secondary to a primary psychiatric disorder

Exclusion Criteria:

  • substance abuse, psychotic symptoms, suicidal intentions, severe organic disorder or psychiatric disorder where sleep restriction is not advised, organic sleep disorder.
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00235365
S2005.2.gr
No
Norwegian University of Science and Technology
Norwegian University of Science and Technology
Not Provided
Principal Investigator: Gunnar Morken, PhD MD Norwegian University of Science and Technology
Norwegian University of Science and Technology
November 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP